A phase II study of a modified FOLFOX6 regimen as neoadjuvant chemotherapy for locally advanced gastric cancer
Bioportfolio,
Related Biotechnology, Pharmaceutical and Healthcare News Original Article: NEXT ARTICLE More From BioPortfolio on "A phase II…